Olympic controversies and GLP-1 for Alzheimer's and Heart Failure

Dr. Karl, an expert in the use of liraglutide for Alzheimer's, and Dr. Spencer, a researcher analyzing heart failure treatments, explore enticing breakthroughs in GLP-1 medications. They delve into promising results from trials that indicate potential benefits for Alzheimer's and heart failure patients. The conversation shifts to the controversial intersection of sports and health metrics, critiquing BMI for athletes and discussing the women's boxing controversy, highlighting the need for more nuanced health assessments in sports.